Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program. [electronic resource]
Producer: 20200210Description: 570-572 p. digitalISSN:- 2374-2445
- Adolescent
- Adult
- Antineoplastic Agents -- adverse effects
- Compassionate Use Trials -- statistics & numerical data
- Drugs, Investigational -- adverse effects
- Female
- Humans
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Program Evaluation
- Treatment Outcome
- United States
- United States Food and Drug Administration
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.